Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Astrocytoma, Grade IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04587830
What this trial is testing

ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme (GBM)
Polaris Group 100
Testing effectiveness (Phase 2)Study completedNCT00998010
What this trial is testing

Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT01149850
What this trial is testing

Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Giant Cell GlioblastomaGlioblastomaGliosarcoma
Jonsson Comprehensive Cancer Center 50
Early research (Phase 1)Study completedNCT00049387
What this trial is testing

Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07604285
What this trial is testing

Safety and Tolerability of MT-125 With Chemoradiation in Patients With Newly Diagnosed MGMT Methylated Glioblastoma

Who this might be right for
Glioblastoma
Myosin Therapeutics Inc. 36
Testing effectiveness (Phase 2)Ended earlyNCT01044225
What this trial is testing

Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma

Who this might be right for
Glioblastoma
Bart Neyns 12
Early research (Phase 1)Study completedNCT00841555
What this trial is testing

Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma

Who this might be right for
Glioblastoma Multiforme/Anaplastic Astrocytoma
Ohio State University Comprehensive Cancer Center 9
Testing effectiveness (Phase 2)WithdrawnNCT00814593
What this trial is testing

Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery

Who this might be right for
Brain and Central Nervous System Tumors
Lisata Therapeutics, Inc.
Testing effectiveness (Phase 2)UnknownNCT05694416
What this trial is testing

Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma

Who this might be right for
MGMT-Unmethylated Glioblastoma
Zhongnan Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00509821
What this trial is testing

Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Eli Lilly and Company 60
Early research (Phase 1)Study completedNCT05938387
What this trial is testing

Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma

Who this might be right for
Glioblastoma
CureVac 37
Testing effectiveness (Phase 2)UnknownNCT00936052
What this trial is testing

Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomasGliosarcoma
Neurological Surgery, P.C. 20
Early research (Phase 1)Study completedNCT01473901
What this trial is testing

A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Novartis Pharmaceuticals 38
Early research (Phase 1)Study completedNCT03615404
What this trial is testing

Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma

Who this might be right for
GlioblastomaMalignant GliomaMedulloblastoma Recurrent+3 more
Gary Archer Ph.D. 11
Testing effectiveness (Phase 2)Looking for participantsNCT05864534
What this trial is testing

Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma

Who this might be right for
Newly Diagnosed GlioblastomaGlioblastoma, Isocitric Dehydrogenase (IDH)-WildtypeGliosarcoma+1 more
Northwestern University 25
Early research (Phase 1)Study completedNCT02709616
What this trial is testing

Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)

Who this might be right for
Glioblastoma
Guangdong 999 Brain Hospital 10
Large-scale testing (Phase 3)Study completedNCT00689221
What this trial is testing

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status

Who this might be right for
Glioblastoma
EMD Serono 545
Large-scale testing (Phase 3)Looking for participantsNCT07195591
What this trial is testing

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

Who this might be right for
Glioblastoma
GT Medical Technologies, Inc. 766
Large-scale testing (Phase 3)UnknownNCT05600491
What this trial is testing

A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme

Who this might be right for
Anaplastic OligoastrocytomaGlioblastoma
Sun Yat-sen University 78
Testing effectiveness (Phase 2)Looking for participantsNCT06816927
What this trial is testing

Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab

Who this might be right for
Newly Diagnosed Glioblastoma
Duke University 92
Next Page